Masaaki Kai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Masaaki Kai has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Takayuki Shibata
Department of Laboratory Sciences, Gunma University Graduate School of Health Sciences
14 shared publications Tsutomu Kabashima
Faculty of Pharmaceutical Sciences, Graduate School of Biomedical Sciences, Nagasaki University, 1-14 Bunkyo-Machi, Nagasaki 852-8521, Japan
14 shared publications- Ahmed. F. M. El-Mahdy
Department of Materials and Optoelectronic Science, National Sun Yat-Sen University, Kaohsiung 80424, Taiwan
4 shared publications Sheng Yin
Faculty of Pharmaceutical Sciences, Graduate School of Biomedical Sciences, Nagasaki University, 1-14 Bunkyo-Machi, Nagasaki 852-8521, Japan
4 shared publicationsQinchang Zhu
Faculty of Pharmaceutical Sciences, Graduate School of Biomedical Sciences, Nagasaki University, 1-14 Bunkyo-Machi, Nagasaki 852-8521, Japan
3 shared publicationsShpend Dragusha
Nagasaki University
3 shared publications
Latest Publications
- Open Access
- 13 January 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 40670
Fluorescence assay of dihydroorotate dehydrogenase that may become a cancer biomarker
We developed an assay method for measuring dihydroorotate dehydrogenase (DHODH) activity in cultured HeLa cells and fibroblasts, and in stage III stomach cancer and adjacent normal tissues from the same patient. The assay comprised enzymatic reaction of DHODH with a large amount of dihydroorotic acid substrate, followed by fluorescence (FL) detection specific for orotic acid using the 4-trifluoromethyl-benzamidoxime fluorogenic reagent. The DHODH activities in the biologically complex samples were readily measured by the assay method. Our data indicate significantly higher DHODH activity in HeLa cells (340 ± 25.9 pmol/105 cells/h) than in normal fibroblasts (54.1 ± 7.40 pmol/105 cells/h), and in malignant tumour tissue (1.10 ± 0.19 nmol/mg total proteins/h) than in adjacent normal tissue (0.24 ± 0.11 nmol/mg total proteins/h). This is the first report that DHODH activity may be a diagnostic biomarker for cancer.
- 13 January 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 40670
Open AccessFluorescence assay of dihydroorotate dehydrogenase that may become a cancer biomarker
We developed an assay method for measuring dihydroorotate dehydrogenase (DHODH) activity in cultured HeLa cells and fibroblasts, and in stage III stomach cancer and adjacent normal tissues from the same patient. The assay comprised enzymatic reaction of DHODH with a large amount of dihydroorotic acid substrate, followed by fluorescence (FL) detection specific for orotic acid using the 4-trifluoromethyl-benzamidoxime fluorogenic reagent. The DHODH activities in the biologically complex samples were readily measured by the assay method. Our data indicate significantly higher DHODH activity in HeLa cells (340 ± 25.9 pmol/105 cells/h) than in normal fibroblasts (54.1 ± 7.40 pmol/105 cells/h), and in malignant tumour tissue (1.10 ± 0.19 nmol/mg total proteins/h) than in adjacent normal tissue (0.24 ± 0.11 nmol/mg total proteins/h). This is the first report that DHODH activity may be a diagnostic biomarker for cancer.
- Open Access
DNA Aptamers in the Diagnosis and Treatment of Human Diseases
Aptamers have a promising role in the field of life science and have been extensively researched for application as analytical tools, therapeutic agents and as vehicles for targeted drug delivery. Compared with RNA aptamers, DNA aptamers have inherent advantages in stability and facility of generation and synthesis. To better understand the specific potential of DNA aptamers, an overview of the progress in the generation and application of DNA aptamers in human disease diagnosis and therapy are presented in this review. Special attention is given to researches that are relatively close to practical application. DNA aptamers are expected to have great potential in the diagnosis and treatment of human diseases.
Open AccessDNA Aptamers in the Diagnosis and Treatment of Human Diseases
Aptamers have a promising role in the field of life science and have been extensively researched for application as analytical tools, therapeutic agents and as vehicles for targeted drug delivery. Compared with RNA aptamers, DNA aptamers have inherent advantages in stability and facility of generation and synthesis. To better understand the specific potential of DNA aptamers, an overview of the progress in the generation and application of DNA aptamers in human disease diagnosis and therapy are presented in this review. Special attention is given to researches that are relatively close to practical application. DNA aptamers are expected to have great potential in the diagnosis and treatment of human diseases.
- Open Access
- 2 November 2015
- Published by MDPI AG
Convenient drug-resistance testing of HIV mutants
Testing for HIV drug resistance is essential to the care of HIV-infected patients. Although direct phenotypic resistance assays are highly reliable, the current recombinant virus-based method is costly and time-consuming. Here, we report a novel fluorometric assay for phenotypic differentiation of drug-resistant mutants of human immunodeficiency virus-I protease (HIV-PR) which uses enzymatic and peptide-specific fluorescence (FL) reactions and high-performance liquid chromatography (HPLC) of three HIV-PR substrates. This assay enables the use of non-purified enzyme sources and multiple substrates for the enzymatic reaction. In this study, susceptibility of HIV mutations to drugs was evaluated by selective formation of three FL products after the enzymatic HIV-PR reaction. This proof-of-concept study indicates that the present HPLC-FL method could be an alternative to current phenotypic assays for the evaluation of HIV drug resistance.
- 2 November 2015
- Published by MDPI AG
Open AccessConvenient drug-resistance testing of HIV mutants
Testing for HIV drug resistance is essential to the care of HIV-infected patients. Although direct phenotypic resistance assays are highly reliable, the current recombinant virus-based method is costly and time-consuming. Here, we report a novel fluorometric assay for phenotypic differentiation of drug-resistant mutants of human immunodeficiency virus-I protease (HIV-PR) which uses enzymatic and peptide-specific fluorescence (FL) reactions and high-performance liquid chromatography (HPLC) of three HIV-PR substrates. This assay enables the use of non-purified enzyme sources and multiple substrates for the enzymatic reaction. In this study, susceptibility of HIV mutations to drugs was evaluated by selective formation of three FL products after the enzymatic HIV-PR reaction. This proof-of-concept study indicates that the present HPLC-FL method could be an alternative to current phenotypic assays for the evaluation of HIV drug resistance.
- 31 May 2015
- Published by Springer Nature in Journal of Fluorescence
- Vol. 25 (4) , 1005-1011
Sensitive and Selective Determination of Orotic Acid in Biological Specimens Using a Novel Fluorogenic Reaction
Orotic acid is an intermediate in the synthesis pathway of uridine-5′-monophosphate, and increases in body fluids of patients suffering from hereditary disorders such as orotic aciduria and hyperammonemia. In this study, we developed a spectrofluorometric method with or without high-performance liquid chromatography for the selective and sensitive quantification of orotic acid in human biological specimens, using 4-trifluoromethylbenzamidoxime (4-TFMBAO) as a fluorogenic reagent. This reagent provided intensive fluorescence for only orotic acid amongst 62 compounds including structurally related bio-substances such as nucleic acid bases, nucleosides, nucleotides, amino acids, vitamins, bilirubin, uric acid, urea, creatine, creatinine and sugars. Under optimized reaction conditions, orotic acid was reacted with 4-TFMBAO, K3[Fe(CN)6] and K2CO3 in an aqueous solution. The fluorescence produced from the orotic acid derivative was measured at an excitation of 340 nm and an emission of 460 nm. A concentration of 1.2 μM orotic acid per 1.0 mM creatinine in normal urine and 0.64 nmol orotic acid per 5.0 × 105 HeLa cells were determined by this method. The present method permitted the facile quantification of orotic acid in healthy human urine and cultured HeLa cells by spectrofluorometry and/or high-performance liquid chromatography.
- 31 May 2015
- Published by Springer Nature in Journal of Fluorescence
- Vol. 25 (4) , 1005-1011
Sensitive and Selective Determination of Orotic Acid in Biological Specimens Using a Novel Fluorogenic Reaction
Orotic acid is an intermediate in the synthesis pathway of uridine-5′-monophosphate, and increases in body fluids of patients suffering from hereditary disorders such as orotic aciduria and hyperammonemia. In this study, we developed a spectrofluorometric method with or without high-performance liquid chromatography for the selective and sensitive quantification of orotic acid in human biological specimens, using 4-trifluoromethylbenzamidoxime (4-TFMBAO) as a fluorogenic reagent. This reagent provided intensive fluorescence for only orotic acid amongst 62 compounds including structurally related bio-substances such as nucleic acid bases, nucleosides, nucleotides, amino acids, vitamins, bilirubin, uric acid, urea, creatine, creatinine and sugars. Under optimized reaction conditions, orotic acid was reacted with 4-TFMBAO, K3[Fe(CN)6] and K2CO3 in an aqueous solution. The fluorescence produced from the orotic acid derivative was measured at an excitation of 340 nm and an emission of 460 nm. A concentration of 1.2 μM orotic acid per 1.0 mM creatinine in normal urine and 0.64 nmol orotic acid per 5.0 × 105 HeLa cells were determined by this method. The present method permitted the facile quantification of orotic acid in healthy human urine and cultured HeLa cells by spectrofluorometry and/or high-performance liquid chromatography.
- Open Access
- 19 May 2015
- Published by Springer Nature in Scientific Reports
- Vol. 5 (1) , 10323
Fluorometric assay for phenotypic differentiation of drug-resistant HIV mutants
Convenient drug-resistance testing of viral mutants is indispensable to effective treatment of viral infection. We developed a novel fluorometric assay for phenotypic differentiation of drug-resistant mutants of human immunodeficiency virus-I protease (HIV-PR) which uses enzymatic and peptide-specific fluorescence (FL) reactions and high-performance liquid chromatography (HPLC) of three HIV-PR substrates. This assay protocol enables use of non-purified enzyme sources and multiple substrates for the enzymatic reaction. In this study, susceptibility of HIV mutations to drugs was evaluated by selective formation of three FL products after the enzymatic HIV-PR reaction. This proof-of-concept study indicates that the present HPLC-FL method could be an alternative to current phenotypic assays for the evaluation of HIV drug resistance.
- 19 May 2015
- Published by Springer Nature in Scientific Reports
- Vol. 5 (1) , 10323
Open AccessFluorometric assay for phenotypic differentiation of drug-resistant HIV mutants
Convenient drug-resistance testing of viral mutants is indispensable to effective treatment of viral infection. We developed a novel fluorometric assay for phenotypic differentiation of drug-resistant mutants of human immunodeficiency virus-I protease (HIV-PR) which uses enzymatic and peptide-specific fluorescence (FL) reactions and high-performance liquid chromatography (HPLC) of three HIV-PR substrates. This assay protocol enables use of non-purified enzyme sources and multiple substrates for the enzymatic reaction. In this study, susceptibility of HIV mutations to drugs was evaluated by selective formation of three FL products after the enzymatic HIV-PR reaction. This proof-of-concept study indicates that the present HPLC-FL method could be an alternative to current phenotypic assays for the evaluation of HIV drug resistance.
- 27 March 2015
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 5 (41) , 32775-32785
Delivery of siRNA using siRNA/cationic vector complexes encapsulated in dendrimer-like polymeric DNAs
Small interfering RNA (siRNA) is a powerful gene silencing tool and has been considered a potential agent for the treatment of many diseases. However, development of safe and effective siRNA delivery systems still remains a great challenge. In this study, we developed a new siRNA delivery system based on the electrostatic encapsulation of siRNA/cationic vector complexes with dendrimer-like polymeric DNAs (YY-DNAs). The binary complexes of siRNA with cationic vectors such as lipofectamine (LP), polyethylenimine (PEI) and poly-L-lysine (PLL) were first constructed. Then, the encapsulation was performed by the addition of YY-DNAs to the binary complexes in order to form stable complexes of siRNA/LP/YY-DNAs, siRNA/PEI/YY-DNAs and siRNA/PLL/YY-DNAs. The encapsulated siRNA complexes showed nearly spherical morphology with about 13–37 nm average hydrodynamic size and their ζ-potentials were negative. The cationic complexes of siRNA/LP, siRNA/PEI and siRNA/PLL showed a high cytotoxicity towards the cells and strong aggregation with erythrocytes, while their encapsulation into YY-DNAs dramatically decreased the toxicities of complexes. Furthermore, these anionic encapsulated siRNA complexes were highly taken up by the HeLa cells and showed extremely high cellular uptake efficiencies and gene silencing effects without such cytotoxicity and aggregation. The stability of these complexes in 10% FBS and human serum was investigated and they showed high stability even after incubation for 72 h and 48 h, respectively. Therefore, we have newly identified safe and efficient anionic complexes of siRNA for clinical uses.
- 27 March 2015
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 5 (41) , 32775-32785
Delivery of siRNA using siRNA/cationic vector complexes encapsulated in dendrimer-like polymeric DNAs
Small interfering RNA (siRNA) is a powerful gene silencing tool and has been considered a potential agent for the treatment of many diseases. However, development of safe and effective siRNA delivery systems still remains a great challenge. In this study, we developed a new siRNA delivery system based on the electrostatic encapsulation of siRNA/cationic vector complexes with dendrimer-like polymeric DNAs (YY-DNAs). The binary complexes of siRNA with cationic vectors such as lipofectamine (LP), polyethylenimine (PEI) and poly-L-lysine (PLL) were first constructed. Then, the encapsulation was performed by the addition of YY-DNAs to the binary complexes in order to form stable complexes of siRNA/LP/YY-DNAs, siRNA/PEI/YY-DNAs and siRNA/PLL/YY-DNAs. The encapsulated siRNA complexes showed nearly spherical morphology with about 13–37 nm average hydrodynamic size and their ζ-potentials were negative. The cationic complexes of siRNA/LP, siRNA/PEI and siRNA/PLL showed a high cytotoxicity towards the cells and strong aggregation with erythrocytes, while their encapsulation into YY-DNAs dramatically decreased the toxicities of complexes. Furthermore, these anionic encapsulated siRNA complexes were highly taken up by the HeLa cells and showed extremely high cellular uptake efficiencies and gene silencing effects without such cytotoxicity and aggregation. The stability of these complexes in 10% FBS and human serum was investigated and they showed high stability even after incubation for 72 h and 48 h, respectively. Therefore, we have newly identified safe and efficient anionic complexes of siRNA for clinical uses.
- 26 September 2014
- Published by Springer Nature in Microchimica Acta
- Vol. 182 (3-4) , 495-503
Facile preparation of streptavidin-coated sephadex beads and their application to chemiluminescence detection of a target DNA
- 26 September 2014
- Published by Springer Nature in Microchimica Acta
- Vol. 182 (3-4) , 495-503
Facile preparation of streptavidin-coated sephadex beads and their application to chemiluminescence detection of a target DNA
- Open Access
- 13 May 2014
- Published by Springer Nature in Scientific Reports
- Vol. 4 (1) , 4950
Amplified and selective assay of collagens by enzymatic and fluorescent reactions
Sensitive and selective assay of collagen is of substantial importance to the diagnostic study of health- and aging-related failures. In this paper, we describe a highly specific and sensitive method for the assay of whole collagens in biological samples using a novel fluorogenic reagent, 3,4-dihydroxyphenylacetic acid (3,4-DHPAA). The 3,4-DHPAA reagent can selectively detect N-terminal Gly-containing peptides (NGPs) in the presence of sodium borate and NaIO4. Under conditions optimized, this assay format for collagen, termed 3,4-DHPAA assay method showed a good linear relationship between the amplified FL signals and the collagen concentrations from 0.18 to 12 μg/ml. Therefore the sensitive determination of intracellular collagens in cheek tissue and HeLa cells was individually possible without any separation protocol. The dual recognitions of the collagens in the samples could be performed by the enzymatic digestion and the FL reaction. The proposed assay method enables the determination facile, specific, sensitive and quantitative for biogenic collagens.
- 13 May 2014
- Published by Springer Nature in Scientific Reports
- Vol. 4 (1) , 4950
Open AccessAmplified and selective assay of collagens by enzymatic and fluorescent reactions
Sensitive and selective assay of collagen is of substantial importance to the diagnostic study of health- and aging-related failures. In this paper, we describe a highly specific and sensitive method for the assay of whole collagens in biological samples using a novel fluorogenic reagent, 3,4-dihydroxyphenylacetic acid (3,4-DHPAA). The 3,4-DHPAA reagent can selectively detect N-terminal Gly-containing peptides (NGPs) in the presence of sodium borate and NaIO4. Under conditions optimized, this assay format for collagen, termed 3,4-DHPAA assay method showed a good linear relationship between the amplified FL signals and the collagen concentrations from 0.18 to 12 μg/ml. Therefore the sensitive determination of intracellular collagens in cheek tissue and HeLa cells was individually possible without any separation protocol. The dual recognitions of the collagens in the samples could be performed by the enzymatic digestion and the FL reaction. The proposed assay method enables the determination facile, specific, sensitive and quantitative for biogenic collagens.
- 1 February 2014
- Published by Elsevier in Clinica Chimica Acta
- Vol. 429, 123-128
Selective, sensitive and fluorometric determination of urinary cytosine with 4-trifluoromethylbenzamidoxime and N,N-dimethylformamide
- 1 February 2014
- Published by Elsevier in Clinica Chimica Acta
- Vol. 429, 123-128
Selective, sensitive and fluorometric determination of urinary cytosine with 4-trifluoromethylbenzamidoxime and N,N-dimethylformamide